pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • VICTOZA
    VICTOZA (LIRAGLUTIDE)
    1 INDICATIONS AND USAGE VICTOZA is indicated: • as an adj…$NVO NOVO NORDISK A S
  • VIGADRONE
    VIGADRONE (VIGABATRIN)
    no indication Aucta Pharmaceuticals Inc
  • Phase 2
    VIM-0423
    Dystonia Vima Therapeutics Inc
  • Phase 1
    VIPER-101
← prev
page 172 of 271
next →
Pain89
Neurology1
Anaplastic Large Cell Lymphoma (ALCL)
ViTToria Biotherapeutics Inc
  • Phase 1
    VIR-5500
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$VIR Vir Biotechnology, Inc.
  • Phase 1
    VIR-5525
    Adenocarcinoma$VIR Vir Biotechnology, Inc.
  • Phase 1
    VIS-171
    Autoimmune Disorders Visterra Inc
  • Phase 1
    VIS-954
    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculiti… Visterra Inc
  • Preclinical
    VIS-DerMap
    Basal Cell Carcinoma (Basal Cell Epithelioma) ArrayPatch Ltd
  • VISINE ALLERGY EYE RELIEF MULTI-ACTION
    VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)
    no indication KENVUE BRANDS
  • VISIONBLUE
    VISIONBLUE (TRYPAN BLUE)
    no indication DORC
  • VITAMIN K1
    VITAMIN K1 (PHYTONADIONE)
    no indication Hospira Inc
  • VITRAKVI
    VITRAKVI (LAROTRECTINIB)
    no indication BAYER HLTHCARE
  • VIVITROL
    VIVITROL (NALTREXONE)
    1 INDICATIONS AND USAGE Treatment with VIVITROL should be…$ALKS Alkermes plc.
  • Phase 1
    VK-0214
    Adrenomyeloneuropathy (AMN)$VIK Viking Holdings Ltd
  • Phase 2
    VK-5211
    Bone Fracture$VIK Viking Holdings Ltd
  • Phase 2
    VL-PX10 + VL-P22
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Vitti Labs LLC
  • Phase 3
    VLA-15
    Lyme Disease$VALN Valneva SE
  • Phase 2
    VLP-001
    Peanut Allergy Allergy Therapeutics Plc
  • Phase 2
    VLPM-01
    Malaria VLP Therapeutics LLC
  • Phase 2
    VLS-1488
    Ovarian Cancer Volastra Therapeutics Inc
  • Phase 1
    VMPAIN-004
    Complex Regional Pain Syndrome (Sympathetic Reflex Dystro… Vivamed BioPharma
  • Phase 2
    VMPSY-002
    Substance (Drug) Abuse Vivamed BioPharma
  • Phase 2
    VMPSY-003
    Opium (Opioid) Addiction Vivamed BioPharma
  • Phase 2
    VMT-01
    Metastatic Melanoma$CATX Perspective Therapeutics, Inc.
  • Phase 2
    VMT-a-NET
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)$CATX Perspective Therapeutics, Inc.
  • Preclinical
    VNLG-152
    Triple-Negative Breast Cancer (TNBC) Isoprene Pharmaceuticals Inc
  • Preclinical
    VNRX-6355
    Neisseria gonorrhoeae Infections VenatoRx Pharmaceuticals Inc
  • Phase 2
    VNX-101
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Vironexis Biotherapeutics Inc
  • Phase 2
    VNX-202
    Gastric Cancer Vironexis Biotherapeutics Inc